These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
409 related articles for article (PubMed ID: 8168405)
21. Transforming growth factor-alpha, epidermal growth factor receptor, and MiB-1 expression in Barrett's-associated neoplasia: correlation with prognosis. Yacoub L; Goldman H; Odze RD Mod Pathol; 1997 Feb; 10(2):105-12. PubMed ID: 9127315 [TBL] [Abstract][Full Text] [Related]
22. 17p allelic losses in diploid cells of patients with Barrett's esophagus who develop aneuploidy. Blount PL; Galipeau PC; Sanchez CA; Neshat K; Levine DS; Yin J; Suzuki H; Abraham JM; Meltzer SJ; Reid BJ Cancer Res; 1994 May; 54(9):2292-5. PubMed ID: 8162566 [TBL] [Abstract][Full Text] [Related]
23. In situ hybridization for the detection of telomerase RNA in the progression from Barrett's esophagus to esophageal adenocarcinoma. Morales CP; Lee EL; Shay JW Cancer; 1998 Aug; 83(4):652-9. PubMed ID: 9708927 [TBL] [Abstract][Full Text] [Related]
24. Progression to cancer in Barrett's esophagus is associated with genomic instability. Rabinovitch PS; Reid BJ; Haggitt RC; Norwood TH; Rubin CE Lab Invest; 1989 Jan; 60(1):65-71. PubMed ID: 2911184 [TBL] [Abstract][Full Text] [Related]
25. Barrett's esophagus: metaplastic cells with loss of heterozygosity at the APC gene locus are clonal precursors to invasive adenocarcinoma. Zhuang Z; Vortmeyer AO; Mark EJ; Odze R; Emmert-Buck MR; Merino MJ; Moon H; Liotta LA; Duray PH Cancer Res; 1996 May; 56(9):1961-4. PubMed ID: 8616831 [TBL] [Abstract][Full Text] [Related]
26. Molecular genetic analysis of surveillance biopsy samples from Barrett's mucosa--significance of sampling. Werther M; Saure C; Pahl R; Schorr F; Rüschoff J; Alles JU; Heinmöller E Pathol Res Pract; 2008; 204(5):285-94. PubMed ID: 18337019 [TBL] [Abstract][Full Text] [Related]
27. Decrease in Le(x) expression in esophageal adenocarcinomas arising in Barrett's epithelium. Engel U; McCombs R; Stranahan P; Pettijohn D; Hage E Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):245-8. PubMed ID: 9107429 [TBL] [Abstract][Full Text] [Related]
28. Genetic mechanisms of TP53 loss of heterozygosity in Barrett's esophagus: implications for biomarker validation. Wongsurawat VJ; Finley JC; Galipeau PC; Sanchez CA; Maley CC; Li X; Blount PL; Odze RD; Rabinovitch PS; Reid BJ Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):509-16. PubMed ID: 16537709 [TBL] [Abstract][Full Text] [Related]
29. Abundant expression of the intestinal protein villin in Barrett's metaplasia and esophageal adenocarcinomas. Regalado SP; Nambu Y; Iannettoni MD; Orringer MB; Beer DG Mol Carcinog; 1998 Jul; 22(3):182-9. PubMed ID: 9688144 [TBL] [Abstract][Full Text] [Related]
30. Diagnostic significance of nuclear p53 expression in the surveillance of Barrett's esophagus--a longitudinal study. Klump B; Hsieh CJ; Holzmann K; Borchard F; Gaco V; Greschniok A; Eckardt VF; Bettendorf U; Gregor M; Porschen R Z Gastroenterol; 1999 Oct; 37(10):1005-11. PubMed ID: 10549095 [TBL] [Abstract][Full Text] [Related]
31. [Morphology and biology of invasion with Barret's carcinoma as an example]. Werner M; Walch A Verh Dtsch Ges Pathol; 2000; 84():62-8. PubMed ID: 11217450 [TBL] [Abstract][Full Text] [Related]